Brazil launches largest Real-World cannabis study to track pain, anxiety, and depression outcomes
NCT ID NCT07362407
First seen Jan 25, 2026 · Last updated Apr 28, 2026 · Updated 15 times
Summary
This study follows 384 Brazilian adults who already have a prescription for cannabis-based products. Researchers will not provide the medication but will track patients for 6 months using online questionnaires. The goal is to see how these treatments affect quality of life, pain, anxiety, and depression in real-world settings, helping doctors and health authorities make safer, more informed decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universidade Federal de Santa Catarina (UFSC), Centro de Ciências Biológicas (CCB), Campus Universitário, Trindade, Florianópolis - SC.
Florianópolis, Santa Catarina, 88049-900, Brazil
Conditions
Explore the condition pages connected to this study.